Wick Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wick Capital Partners's BMY Position: Q2 2026 in Review
Wick Capital Partners increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $86K and bringing the position to 14,034 shares worth $809K. The position accounts for 0.12% of the portfolio, ranked #69.
Wick Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wick Capital Partners held 14,034 shares of Bristol-Myers Squibb worth $809K as of Q2 2026.
- Wick Capital Partners bought 1,498 Bristol-Myers Squibb shares in Q2 2026, an estimated $86K.
- Bristol-Myers Squibb made up 0.12% of Wick Capital Partners's portfolio in Q2 2026, its #69 holding.
- Wick Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wick Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.